Shanghai Sanyou Medical Co., Ltd.

SSE:688085.SS

19.83 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Revenue 116.434120.862120.657123.97385.378100.24176.703121.385160.839167.619184.881167.145129.508174.621157.776142.78118.182121.657118.378100.73449.66498.95294.34189.47671.55164.226
Cost of Revenue 30.43829.13133.29637.0436.04225.60425.10623.12923.34816.3118.64916.80912.00215.72815.94512.34912.34910.44911.7827.9135.48810.2537.4266.5246.7536.804
Gross Profit 85.99691.73187.36286.93349.33674.63651.59798.256137.491151.31166.232150.336117.506158.893141.831130.432105.833111.208106.59692.82144.17588.69986.91582.95264.79757.421
Gross Profit Ratio 0.7390.7590.7240.7010.5780.7450.6730.8090.8550.9030.8990.8990.9070.910.8990.9140.8960.9140.90.9210.8890.8960.9210.9270.9060.894
Reseach & Development Expenses 18.097020.08525.04817.2616.12117.26715.56314.26917.09918.04212.92712.30819.72115.66411.9819.18614.2117.0448.0624.6015.3274.2655.2393.6190
General & Administrative Expenses 13.667036.487-6.09412.06-9.72715.508-0.8867.679-9.06319.362-2.4186.459-7.66514.681-0.6525.176-4.7743.713-1.4834.0074.9694.033-1.0322.8580
Selling & Marketing Expenses 35.806064.56940.51926.86618.24226.27839.56477.40765.98288.35978.85463.76280.51478.5472.7962.92560.81153.66747.69623.74750.49548.88542.43334.2150
SG&A 49.474-40.302101.05651.32137.31924.92641.78738.67985.08656.92107.72176.43670.2272.84993.2272.13868.156.03757.3846.21327.75456.06252.91841.437.0730
Other Expenses 4.008105.905-43.714-6.914-2.101-2.6472.879.9-2.41822.088-9.87911.0531.4910.4033.6516.5032.7552.1284.0720.3630.002-61.2280.0054.62-0.018-36.943
Operating Expenses 71.57985.92777.42783.28356.68143.69450.92960.62496.93796.107115.884100.41684.019109.711103.81292.2878.58484.24564.87260.34332.834-61.22857.69951.13641.264-36.943
Operating Income 14.417-0.5129.9353.65-7.34430.9422.85730.0643.184.38836.10853.10438.30486.32443.5541.38232.76740.48645.13430.60214.16127.4727.90930.57823.38220.478
Operating Income Ratio 0.124-0.0040.0820.029-0.0860.3090.0370.2480.2680.5030.1950.3180.2960.4940.2760.290.2770.3330.3810.3040.2850.2780.2960.3420.3270.319
Total Other Income Expenses Net -0.0346.0071.069-0.0730.151.7122.879.9-0.0391.6698.6890.123-0.0340.4033.6516.5032.7552.1284.0720.3630.0020.0130.0054.62-0.018-0.047
Income Before Tax 14.3845.49611.0056.766-1.36346.1225.72739.9643.0686.05861.98753.22738.2786.72747.20147.88535.52242.61449.20530.96414.16327.48327.91435.19823.36420.431
Income Before Tax Ratio 0.1240.0450.0910.055-0.0160.460.0750.3290.2680.5130.3350.3180.2960.4970.2990.3350.3010.350.4160.3070.2850.2780.2960.3930.3270.318
Income Tax Expense 3.7911.5733.9721.7432.5037.7021.0534.5217.95310.90411.2548.2775.555.0414.1967.3695.5753.8587.4164.8622.252149.5494.2415.3333.56591.408
Net Income 12.8232.8986.8943.772-2.09629.2943.37128.26434.65366.20447.95843.48933.16772.92642.98240.51629.94638.75641.78926.10211.91124.72223.67429.83919.58418.303
Net Income Ratio 0.110.0240.0570.03-0.0250.2920.0440.2330.2150.3950.2590.260.2560.4180.2720.2840.2530.3190.3530.2590.240.250.2510.3330.2740.285
EPS 0.050.0160.0280.015-0.0080.120.0140.110.140.270.230.210.150.290.220.20.120.190.170.180.0660.160.120.20.110.12
EPS Diluted 0.050.0160.0280.015-0.0080.120.0140.110.140.270.230.210.150.290.220.20.120.190.170.180.0660.160.120.20.110.12
EBITDA 18.202-0.51211.55622.4891.63662.72522.3350.54853.64799.3543.96258.08533.48794.47554.77254.44542.01947.68746.74735.53315.39-119.31729.21531.81724.499-68.801
EBITDA Ratio 0.156-0.0040.0960.1810.0190.6260.2910.4160.3340.5930.2380.3480.2590.5410.3470.3810.3560.3920.3950.3530.31-1.2060.310.3560.342-1.071